The NASP Education Committee welcomes submission of original or encore research relevant to specialty pharmacy, outcomes related to specialty pharmacy products or services provided by specialty pharmacies. Accepted abstracts will be presented at the 7th Annual NASP Annual Meeting & Expo to be held September 9-12, 2019 and published online through the PubMed-indexed Journal of Drug Assessment. 

Deadline for submission has passed. 

If your abstract has been accepted, and you are shipping your poster directly to the Washington Marriott Wardman Park Hotel, please use the following shipping address to do so. Please note, the retriever will be responsible for any incurred fees when retrieving the package from the hotel. 

Washington Marriott Wardman Park Hotel

Attention: Your Name or Name of Who Will Retrieve Package

NASP Annual Meeting & Expo

2660 Woodley Road NW

Washington, DC 20008

Posters cannot exceed 4' tall and 8' wide.  It must reflect hte submitted abstract; i.e. abstract title, authorship, and content must match thes ubmitted abstract.


All abstracts must be submitted online, using template below. 

Your abstract should be a short description of your research/work in specialty pharmacy, containing all the elements necessary to define your goals and results to the reader. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. Continuing education credits are not available for the posters.

Share your research or best practices with your peers. Categories of submission include:

  • Delivery of Specialty Pharmacy Products or Services
  • Adherence
  • Outcomes (Cost or other)
  • Student Research


Note: Abstract submissions must reflect completed research. Submissions of previously presented research are permitted.

The Education Committee will evaluate the abstracts based on the following criteria: novelty of the research, significance of the findings, relevance to specialty pharmacy, and clarity. Incomplete abstracts will not be accepted.

Notification of acceptance, or regret, will be delivered via e-mail to the presenter(s) of each poster abstract, by July 19, 2019. Please note that an author is required to be present during the poster session on Tuesday evening, September 10, 2019.

If accepted for presentation, abstracts and posters will be available for viewing during the National Association of Specialty Pharmacy 7th Annual Meeting & Expo. The posters will be displayed for the length of the meeting and announcement of the top posters will be made at the start of the general session on Wednesday morning, September 11, 2019. The presentation at the annual meeting must match the submitted abstract title, authorship, and content.

At least one author must register to attend the National Association of Specialty Pharmacy 7th Annual Meeting & Expo, be identified on the abstract submission as the presenting author and be present during the poster session on Tuesday evening, September 10, 2019.


Abstract format

  • The title of the abstract should be brief, objectively describing the study. Do not use non-standard abbreviations and commercial names (generic names only). Capitalize only the first word and any proper nouns.
  • No more than 10 authors can be listed with institutional affiliations, cities and countries only. Mailing addresses and academic degrees should not be mentioned in the author's list. For cooperative study groups, you may give the name of the group instead of individual institutional affiliations or include the name of the group in the title of the abstract.
  • Presenting Author: The name, degrees(s), title/primary affiliation, email address, and telephone number of the Presenting Author is required. The Presenting Author will receive all future correspondence from the National Association of Specialty Pharmacy (NASP).
  • Abstracts limited to 2500 characters (abstract body, including spaces).
  • Abstracts should be structured in such a way as to include the following 5 sections:
    • Background/Significance -- What was the problem and why was it important? What knowledge are you building on?
    • Objectives -- What was the intent or goal of the study? What did you want to learn?
    • Methods -- What was the trial design? What was the sample? What instruments were used? How were data collected and analyzed?
    • Results -- What were the findings?
    • Conclusions -- What do the findings mean?
  • Tables, illustrations and/or figures are not allowed and will be deleted if submitted.
  • Abbreviations may be used if standard or if spelled out and defined at the first use (put in parentheses immediately after the first mention of a term or phrase). Compounds should be mentioned with the generic name, in lower cases. Commercial names may be included in the abstract text in parentheses with an ®, directly following the generic name at first use, i.e. "generic (Commercial ®)".
  • If an error is detected after submission, please notify Tiffany Fattizzi via email at abstracts@naspmeeting.com prior to the June 14, 2019 submission deadline to have the error corrected prior to the start of poster abstract review.
  • The abstract must be submitted in English.


Submission Process

  • After submission, a confirmation e-mail will be sent to submitter.


Abstract Questions 

Please submit any questions pertaining to abstract submissions to abstracts@naspmeeting.com using the subject line "NASP 2019 Annual Meeting Abstract Question." 

Author Consent and Waiver of Claims

  • Each abstract author agrees and certifies that he or she:
    • Waives any, and all claims against National Association of Specialty Pharmacy, sponsor of the National Association of Specialty Pharmacy 7th Annual Meeting & Expo, and any review arising out of or relating to the abstract submission and review process, including but not limited to peer review and the grading of abstracts.


2018 Abstract Winners

Top Poster – Attendee Selection

Implementation of a Novel, Pharmacist-led Digital Medicine Program in Patients Prescribed Oral Hepatitis C Treatment


Kimberly Tynik


First Place: Adherence

Impact of Comprehensive Pharmacy Services on Patient-Centered Outcomes in a Hematology and Oncology Clinic


Natalie Blaine


First Place: Delivery of Specialty Pharmacy Products or Services

Technology-enabled Specialty Pharmacy Utilization of the Routine Assessment of Patient Index Data 3 (RAPID3) to Monitor and Enhance Outcomes of Rheumatoid Arthritis (RA) Patients – A Retrospective Review


Lily Duong


First Place: Outcomes

Clinical and Economic Impact of a Comprehensive Specialty Pharmacy Oral Oncology Patient Management Program


Adam Saulles